Malignant mesothelioma of the ovary: a case report

Primary malignant mesothelioma of the ovary (PMMO) is an extremely rare tumor which can develop from mesothelial cells. This neoplasia is caused predominantly by exposure to asbestos or other cancer-causing agents. Preoperative assessment, based on computed tomography (CT) scan, magnetic resonance i...

Full description

Saved in:
Bibliographic Details
Published inThe Pan African medical journal Vol. 38; p. 92
Main Authors Ouafki, Imane, Nouiakh, Lamyae, Boujarnija, Raihana, Amarti, Afaf, Amaadour, Lamiae, Oualla, Karima, Benbrahim, Zineb, Arifi, Samia, Mellas, Nawfel
Format Journal Article
LanguageFrench
Published Uganda 27.01.2021
Subjects
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Humans
Mesothelioma, Malignant - diagnosis
Mesothelioma, Malignant - pathology
Mesothelioma, Malignant - therapy
Middle Aged
Neoplasm Staging
Ovarian Neoplasms - diagnosis
Ovarian Neoplasms - pathology
Ovarian Neoplasms - therapy
Tomography, X-Ray Computed
Mesothelioma
case report
ovary
primitive
chemotherapy
Online AccessGet full text

Cover

More Information
Summary:Primary malignant mesothelioma of the ovary (PMMO) is an extremely rare tumor which can develop from mesothelial cells. This neoplasia is caused predominantly by exposure to asbestos or other cancer-causing agents. Preoperative assessment, based on computed tomography (CT) scan, magnetic resonance imaging and positron emission tomography, is essential for cancer staging. Anatomopathological diagnosis is based on immunohistochemical findings. PMMO is an exceptional disease involving a multidisciplinary therapeutic strategy including the use of chemotherapy which improves the management and prognosis of patients. This study reports the case of a female patient undergoing suboptimal surgery complemented by adjuvant chemotherapy with complete radiological response and 1-year disease-free survival.
ISSN:1937-8688
DOI:10.11604/pamj.2021.38.92.24462